ESR1 and breast cancer: Considering these data, the aim of the present study was to analyze the relationship between AR/ER ratio and proliferation markers (AURKA, BIRC5, CCNB1, MKI67 and UBE2C) in BC cases grouped according to their AR/ER ratio levels (<2 vs. ≥2).